Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of KalVista Pharmaceuticals Inc (NASDAQ: KALV) closed at $10.07 in the last session, down -0.79% from day before closing price of $10.15. In other words, the price has decreased by -$0.79 from its previous closing price. On the day, 0.97 million shares were traded. KALV stock price reached its highest trading level at $10.44 during the session, while it also had its lowest trading level at $9.97.
Ratios:
We take a closer look at KALV’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.55 and its Current Ratio is at 8.55. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on June 15, 2020, initiated with a Buy rating and assigned the stock a target price of $30.
On July 29, 2019, SVB Leerink started tracking the stock assigning a Outperform rating and target price of $31.
On March 20, 2019, Needham started tracking the stock assigning a Buy rating and target price of $35.Needham initiated its Buy rating on March 20, 2019, with a $35 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 18 ’24 when Palleiko Benjamin L sold 14,400 shares for $9.26 per share. The transaction valued at 133,294 led to the insider holds 266,598 shares of the business.
Yea Christopher sold 7,192 shares of KALV for $66,573 on Nov 18 ’24. The CHIEF DEVELOPMENT OFFICER now owns 89,980 shares after completing the transaction at $9.26 per share. On Nov 18 ’24, another insider, Audhya Paul K., who serves as the CHIEF MEDICAL OFFICER of the company, sold 8,077 shares for $9.26 each. As a result, the insider received 74,766 and left with 94,199 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KALV now has a Market Capitalization of 499537440 and an Enterprise Value of 267159808.
Stock Price History:
Over the past 52 weeks, KALV has reached a high of $16.88, while it has fallen to a 52-week low of $7.39. The 50-Day Moving Average of the stock is -8.50%, while the 200-Day Moving Average is calculated to be -16.77%.
Shares Statistics:
According to the various share statistics, KALV traded on average about 401.75K shares per day over the past 3-months and 521750 shares per day over the past 10 days. A total of 42.52M shares are outstanding, with a floating share count of 32.34M. Insiders hold about 33.62% of the company’s shares, while institutions hold 75.33% stake in the company. Shares short for KALV as of 1730332800 were 6872823 with a Short Ratio of 17.11, compared to 1727654400 on 6508122. Therefore, it implies a Short% of Shares Outstanding of 6872823 and a Short% of Float of 18.310000000000002.
